"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","15/99","30/2914",3.22798538902167e-15,2.13369834214332e-12,1.29119415560867e-12,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/MAPK11/MAPK9/PPP2CA/MEF2A/ELK1",15
"R-HSA-450294","R-HSA-450294","MAP kinase activation","19/99","60/2914",1.41245825357171e-14,4.66817452805451e-12,2.82491650714343e-12,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",19
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","19/99","64/2914",5.40884603367256e-14,1.19174907608585e-11,7.21179471156341e-12,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",19
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","47/99","481/2914",2.42463086616377e-13,2.29144700880587e-11,1.38665477083563e-11,"CTNNB1/E2F1/EGFR/AKT1/CAMK4/CREBBP/MAPK1/MAPK3/PRKAA1/PRKAA2/SMAD3/TP53/YAP1/AXIN1/CREB1/EP300/GSK3B/MDM2/MDM4/PRKACA/RB1/ATF2/JUN/MAPK14/PPARGC1A/STK11/AR/MYB/MAPK11/DAXX/HDAC1/PRKCB/PPP2CA/SRC/AKT2/AKT3/TCF7L2/TP73/SPI1/TWIST1/NR2C2/SREBF1/TEAD4/YY1/BCL6/ESRRA/SP1",47
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","20/99","78/2914",2.42664584896234e-13,2.29144700880587e-11,1.38665477083563e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","20/99","78/2914",2.42664584896234e-13,2.29144700880587e-11,1.38665477083563e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","20/99","78/2914",2.42664584896234e-13,2.29144700880587e-11,1.38665477083563e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","9/99","10/2914",4.08085400649385e-13,3.37180562286554e-11,2.04042700324693e-11,"MAPK10/MAPK1/MAPK3/ATF2/JUN/MAPK14/MAPK8/MAPK11/MAPK9",9
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","20/99","83/2914",8.76808266548512e-13,6.17147320356079e-11,3.73462826236659e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","47/99","499/2914",1.01823927821951e-12,6.17147320356079e-11,3.73462826236659e-11,"CTNNB1/E2F1/EGFR/AKT1/CAMK4/CREBBP/MAPK1/MAPK3/PRKAA1/PRKAA2/SMAD3/TP53/YAP1/AXIN1/CREB1/EP300/GSK3B/MDM2/MDM4/PRKACA/RB1/ATF2/JUN/MAPK14/PPARGC1A/STK11/AR/MYB/MAPK11/DAXX/HDAC1/PRKCB/PPP2CA/SRC/AKT2/AKT3/TCF7L2/TP73/SPI1/TWIST1/NR2C2/SREBF1/TEAD4/YY1/BCL6/ESRRA/SP1",47
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","20/99","84/2914",1.12038847870998e-12,6.17147320356079e-11,3.73462826236659e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","20/99","84/2914",1.12038847870998e-12,6.17147320356079e-11,3.73462826236659e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","20/99","86/2914",1.8094595588785e-12,7.97368512279125e-11,4.82522549034267e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","20/99","86/2914",1.8094595588785e-12,7.97368512279125e-11,4.82522549034267e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","20/99","86/2914",1.8094595588785e-12,7.97368512279125e-11,4.82522549034267e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","20/99","87/2914",2.28743524853614e-12,8.39997055156882e-11,5.08318944119142e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","20/99","87/2914",2.28743524853614e-12,8.39997055156882e-11,5.08318944119142e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","20/99","87/2914",2.28743524853614e-12,8.39997055156882e-11,5.08318944119142e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","20/99","90/2914",4.52955972498982e-12,1.49701948910914e-10,9.05911944997964e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","20/99","90/2914",4.52955972498982e-12,1.49701948910914e-10,9.05911944997964e-11,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","14/99","44/2914",5.35855983000513e-11,1.68667049887304e-09,1.02067806285812e-09,"E2F1/MAPK10/MAPK1/MAPK3/TP53/MDM2/MDM4/JUN/MAPK14/MAPK8/MAP2K4/MAPK11/MAPK9/MAP3K5",14
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","20/99","110/2914",2.27924569658165e-10,6.84809729745668e-09,4.14408308469391e-09,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","19/99","99/2914",2.58133973377229e-10,7.4185459305369e-09,4.48928649351703e-09,"E2F1/MAPK10/STAT3/MAPK1/MAPK3/TP53/MDM2/MDM4/RB1/JUN/MAPK14/MAPK8/MAP2K4/MAPK11/MAPK9/MAP3K5/RELA/CEBPB/SP1",19
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","16/99","70/2914",5.12555269087836e-10,1.41166263694608e-08,8.54258781813061e-09,"AP2M1/STAT3/MAPK1/MAPK3/CREB1/RPS6KA5/DUSP7/MAPK14/GRB2/MAPK11/MAPK12/PPP2CA/RALA/SRC/MEF2A/ELK1",16
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","19/99","108/2914",1.24371211030011e-09,3.2883748196335e-08,1.98993937648018e-08,"EGFR/AKT1/CREBBP/MAPK1/MAPK3/AXIN1/CREB1/EP300/ATF2/JUN/MYB/HDAC1/SRC/AKT2/AKT3/ELK1/FOXA1/YY1/SP1",19
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","37/99","397/2914",1.3369729269373e-09,3.39899655655982e-08,2.05688142605738e-08,"AP2M1/CTNNB1/E2F1/EGFR/STAT3/VAV2/AKT1/CREBBP/MAPK1/MAPK3/SMAD3/CREB1/EP300/GSK3B/PRKACA/RPS6KA5/JUN/MAPK14/MAPK8/PPARGC1A/MYB/CXCR4/GRB2/FLI1/MAPK11/MAPK12/RELA/SRC/AKT2/AKT3/RET/SH3KBP1/MEF2A/SPI1/SREBF1/YY1/CEBPB",37
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","12/99","38/2914",1.5749316394922e-09,3.85566597668276e-08,2.33323205850696e-08,"CAMK4/CREBBP/PRKAA2/CREB1/ATF2/MAPK14/PPARGC1A/MAPK11/MAPK12/NRF1/GABPA/ESRRA",12
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","10/99","24/2914",1.71703034872529e-09,4.05341807324079e-08,2.45290049817899e-08,"MAPK1/MAPK3/CREB1/RPS6KA5/DUSP7/MAPK14/MAPK11/PPP2CA/MEF2A/ELK1",10
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","20/99","127/2914",3.3072820141263e-09,7.53832210806028e-08,4.56176829534662e-08,"MAPK10/MAPK1/MAPK3/CREB1/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/MAP3K7/MEF2A/ELK1",20
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","25/99","201/2914",4.35816141527207e-09,9.60248231831614e-08,5.81088188702943e-08,"EGFR/AKT1/CAMK4/CAMKK2/MAPK1/MAPK3/TP53/CREB1/GSK3B/MDM2/PHLPP1/PRKACA/ATF2/JUN/TRAF6/GRB2/PRKCD/HDAC1/CHUK/GSK3A/PPP2CA/SRC/AKT2/AKT3/EGR1",25
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","9/99","21/2914",8.78789808610981e-09,1.87380665642535e-07,1.13392233369159e-07,"MAPK1/MAPK3/RPS6KA5/DUSP7/MAPK14/MAPK11/PPP2CA/MEF2A/ELK1",9
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","20/99","136/2914",1.13745858742755e-08,2.34956289465502e-07,1.42182323428443e-07,"EGFR/AKT1/CREBBP/MAPK1/MAPK3/AXIN1/CREB1/EP300/ATF2/JUN/MYB/HDAC1/SRC/AKT2/AKT3/ELK1/SREBF1/FOXA1/YY1/SP1",20
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","16/99","89/2914",2.15461914576715e-08,4.31576744046086e-07,2.61165957062685e-07,"AP2M1/STAT3/MAPK1/MAPK3/CREB1/RPS6KA5/DUSP7/MAPK14/GRB2/MAPK11/MAPK12/PPP2CA/RALA/SRC/MEF2A/ELK1",16
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","23/99","187/2914",2.60451305986825e-08,5.06347980168503e-07,3.0641330116097e-07,"E2F1/MAPK10/STAT3/CREBBP/MAPK1/MAPK3/TP53/EP300/GSK3B/MDM2/MDM4/RB1/JUN/MAPK14/MAPK8/AR/MAP2K4/MAPK11/MAPK9/MAP3K5/RELA/CEBPB/SP1",23
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","23/99","189/2914",3.20278406843233e-08,6.04868648352505e-07,3.66032464963694e-07,"E2F1/MAPK10/STAT3/CREBBP/MAPK1/MAPK3/TP53/EP300/GSK3B/MDM2/MDM4/RB1/JUN/MAPK14/MAPK8/AR/MAP2K4/MAPK11/MAPK9/MAP3K5/RELA/CEBPB/SP1",23
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","31/99","332/2914",4.85783794657053e-08,8.91953022967533e-07,5.3975977184117e-07,"MAPK10/STAT3/AKT1/MAPK1/MAPK3/SMAD3/TP53/CREB1/PRKACA/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/CASP3/TRAF6/GRB2/MAP2K4/MAPK11/MAPK9/RELA/CHUK/PPP2CA/RALA/JAK2/MAP3K7/MEF2A/TWIST1/ELK1/BCL6",31
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","16/99","95/2914",5.70245562582397e-08,1.01873599153234e-06,6.16481689278267e-07,"AKT1/PRKAA1/PRKAA2/TP53/EP300/MDM2/MDM4/MAPK14/STK11/MAPK11/DAXX/HDAC1/PPP2CA/AKT2/AKT3/TP73",16
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","7/99","13/2914",6.1420450593873e-08,1.06839257480395e-06,6.46531058882873e-07,"AKT1/GSK3B/MDM2/CHUK/GSK3A/AKT2/AKT3",7
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","13/99","62/2914",7.62199043493926e-08,1.29182966089612e-06,7.81742608711719e-07,"AKT1/MAPK1/MAPK3/YAP1/GSK3B/RB1/PPARGC1A/AR/SRC/AKT2/AKT3/TWIST1/ESRRA",13
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","27/99","268/2914",9.64889137819071e-08,1.59447930024602e-06,9.64889137819071e-07,"ARRB2/CTNNB1/EGFR/STAT3/AKT1/CREBBP/MAPK1/MAPK3/SMAD3/AXIN1/CREB1/CSNK1A1/EP300/GSK3B/MDM2/GRB2/LRP6/HDAC1/PHB/CHUK/GSK3A/PPP2CA/SRC/AKT2/AKT3/JAK2/TCF7L2",27
"R-HSA-1643685","R-HSA-1643685","Disease","36/99","443/2914",1.08125643641046e-07,1.74319635235931e-06,1.05488432820533e-06,"AP2M1/ARRB2/CTNNB1/EGFR/STAT3/AKT1/CAMK4/CREBBP/MAPK1/MAPK3/SMAD3/AXIN1/CDC25A/CREB1/CSNK1A1/EP300/GSK3B/MDM2/PRKACA/JUN/CXCR4/GRB2/LRP6/MAP2K4/HDAC1/PHB/RELA/CHUK/GSK3A/PPP2CA/SRC/AKT2/AKT3/JAK2/SH3KBP1/TCF7L2",36
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","21/99","172/2914",1.35751440990455e-07,2.13646910701644e-06,1.29287086657576e-06,"EGFR/AKT1/MAPK1/MAPK3/TP53/CREB1/GSK3B/MDM2/PHLPP1/ATF2/JUN/TRAF6/GRB2/HDAC1/CHUK/GSK3A/PPP2CA/SRC/AKT2/AKT3/EGR1",21
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","14/99","80/2914",2.56694214567228e-07,3.94592734485901e-06,2.38785315876491e-06,"CAMK4/CREBBP/PRKAA2/CREB1/PRKACA/SMO/ATF2/MAPK14/PPARGC1A/MAPK11/MAPK12/NRF1/GABPA/ESRRA",14
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","9/99","30/2914",3.31621894344295e-07,4.98186527639953e-06,3.01474449403905e-06,"MAPK10/VAV2/MAPK1/MAPK3/JUN/MAPK8/GRB2/MAP2K4/MAPK9",9
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","11/99","49/2914",3.97150297903642e-07,5.70687710683277e-06,3.45348085133602e-06,"E2F1/STAT3/AKT1/MAPK1/MAPK3/TP53/MAPK8/CASP3/AKT2/AKT3/TP73",11
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","11/99","49/2914",3.97150297903642e-07,5.70687710683277e-06,3.45348085133602e-06,"AKT1/CREBBP/SMAD3/EP300/PPARGC1A/STK11/HDAC1/AKT2/AKT3/SREBF1/BCL6",11
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","8/99","23/2914",4.3046309223605e-07,6.05395965889424e-06,3.66351567860468e-06,"E2F1/MAPK1/MAPK3/TP53/MDM2/MDM4/RB1/SP1",8
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","8/99","24/2914",6.27738887582979e-07,8.46806948351733e-06,5.12439908231003e-06,"AKT1/CREB1/GSK3B/MDM2/CHUK/GSK3A/AKT2/AKT3",8
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","8/99","24/2914",6.27738887582979e-07,8.46806948351733e-06,5.12439908231003e-06,"EGFR/AKT1/MAPK1/MAPK3/CREB1/AKT2/AKT3/ELK1",8
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","14/99","87/2914",7.56266757917187e-07,9.99784653966522e-06,6.0501340633375e-06,"MAPK10/VAV2/MAPK1/MAPK3/JUN/MAPK8/TRAF6/GRB2/MAP2K4/MAPK9/RELA/CHUK/MAP3K7/NFATC1",14
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","21/99","194/2914",1.08481616259431e-06,1.40600683034282e-05,8.5083620595632e-06,"E2F1/AKT1/CREBBP/PRKAA1/PRKAA2/TP53/EP300/MDM2/MDM4/ATF2/JUN/MAPK14/STK11/MAPK11/DAXX/HDAC1/PPP2CA/AKT2/AKT3/TP73/BCL6",21
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","8/99","27/2914",1.74117680884215e-06,2.21330359739358e-05,1.33936677603243e-05,"E2F1/STAT3/CREB1/EP300/MYB/FLI1/SPI1/CEBPB",8
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","8/99","29/2914",3.18172679140304e-06,3.82808621486223e-05,2.31654233879711e-05,"AKT1/TP53/MDM2/MDM4/DAXX/PPP2CA/AKT2/AKT3",8
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","8/99","29/2914",3.18172679140304e-06,3.82808621486223e-05,2.31654233879711e-05,"AKT1/TP53/MDM2/MDM4/DAXX/PPP2CA/AKT2/AKT3",8
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","6/99","14/2914",3.18524571584603e-06,3.82808621486223e-05,2.31654233879711e-05,"AKT1/TP53/EP300/HDAC1/AKT2/AKT3",6
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","10/99","49/2914",3.54591299341566e-06,4.18544372972813e-05,2.5327949952969e-05,"CREBBP/AXIN1/EP300/ATF2/JUN/MYB/HDAC1/FOXA1/YY1/SP1",10
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","28/99","347/2914",5.62071040686375e-06,6.51805189287182e-05,3.94435818025526e-05,"AP2M1/CTNNB1/EGFR/STAT3/VAV2/AKT1/MAPK1/MAPK3/YAP1/CREB1/PRKACA/RPS6KA5/DUSP7/MAPK14/GRB2/MAPK11/MAPK12/PRKCD/PRKCB/PPP2CA/RALA/SRC/AKT2/AKT3/JAK2/SH3KBP1/MEF2A/ELK1",28
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","12/99","77/2914",7.10831144367956e-06,8.02716420781301e-05,4.85758802288231e-05,"AP2M1/CAMK4/CAMKK2/MAPK1/MAPK3/PRKAA1/PRKAA2/CREB1/MDM2/PRKACA/PRKCB/SRC",12
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","8/99","32/2914",7.1649423337514e-06,8.02716420781301e-05,4.85758802288231e-05,"CAMK4/CREBBP/CREB1/ATF2/PPARGC1A/NRF1/GABPA/ESRRA",8
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","10/99","53/2914",7.51271052555329e-06,8.27650276231787e-05,5.00847368370219e-05,"CTNNB1/CREBBP/SMAD3/TP53/YAP1/EP300/MDM2/SRC/TCF7L2/TEAD4",10
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","6/99","16/2914",8.03585901689092e-06,8.70770952486049e-05,5.26941574878093e-05,"MAPK1/MAPK3/MAPK14/MAPK11/PRKCD/PRKCB",6
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","5/99","10/2914",9.01274908608613e-06,9.60875346113376e-05,5.81467682973299e-05,"AKT1/TP53/AKT2/AKT3/TP73",5
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","8/99","33/2914",9.19493422070893e-06,9.64738336490254e-05,5.83805347346599e-05,"MAPK1/MAPK3/MAPK14/GRB2/MAPK11/MAPK12/RALA/SRC",8
"R-HSA-168249","R-HSA-168249","Innate Immune System","31/99","428/2914",1.48596523384937e-05,0.000153472346808505,9.28728271155856e-05,"CTNNB1/MAPK10/VAV2/CREBBP/MAPK1/MAPK3/CREB1/EP300/PRKACA/RPS6KA5/ATF2/DUSP7/JUN/MAPK14/MAPK8/TRAF6/GRB2/MAP2K4/MAPK11/MAPK12/MAPK9/PRKCD/RELA/CHUK/PLD2/PPP2CA/SRC/MAP3K7/MEF2A/NFATC1/ELK1",31
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","9/99","47/2914",1.95298107014442e-05,0.000198603151902379,0.000120183450470426,"CAMK4/CAMKK2/MAPK1/MAPK3/PRKAA1/PRKAA2/CREB1/PRKACA/SRC",9
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","12/99","85/2914",2.02924039608279e-05,0.000201499436873899,0.000121936119137004,"CTNNB1/VAV2/AKT1/PRKACA/MAPK14/MAPK11/MAPK12/PRKCD/PRKCB/SRC/AKT2/AKT3",12
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","10/99","59/2914",2.04242999554481e-05,0.000201499436873899,0.000121936119137004,"AKT1/MAPK1/MAPK3/TP53/ATF2/JUN/HDAC1/AKT2/AKT3/EGR1",10
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","11/99","72/2914",2.14819514773435e-05,0.000208817204801824,0.000126364420454962,"CREBBP/EP300/PRKACA/RPS6KA5/TRAF6/PRKCD/RELA/CHUK/SRC/MAP3K7/NFATC1",11
"R-HSA-109581","R-HSA-109581","Apoptosis","13/99","101/2914",2.49166688873142e-05,0.000236594254365205,0.000143173527603755,"CTNNB1/E2F1/STAT3/AKT1/MAPK1/MAPK3/TP53/MAPK8/CASP3/PRKCD/AKT2/AKT3/TP73",13
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","6/99","19/2914",2.50553673306571e-05,0.000236594254365205,0.000143173527603755,"MAPK1/MAPK3/YAP1/RB1/AR/SRC",6
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","9/99","49/2914",2.78263720010306e-05,0.000259059604122271,0.000156768292963553,"CAMK4/CAMKK2/MAPK1/MAPK3/PRKAA1/PRKAA2/CREB1/PRKACA/SRC",9
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","12/99","88/2914",2.90961313378982e-05,0.000267118650199315,0.000161645174099434,"AP2M1/CAMK4/CAMKK2/MAPK1/MAPK3/PRKAA1/PRKAA2/CREB1/MDM2/PRKACA/PRKCB/SRC",12
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","13/99","103/2914",3.0883724146948e-05,0.000279645776179899,0.000169225885736701,"CTNNB1/E2F1/STAT3/AKT1/MAPK1/MAPK3/TP53/MAPK8/CASP3/PRKCD/AKT2/AKT3/TP73",13
"R-HSA-167044","R-HSA-167044","Signalling to RAS","6/99","20/2914",3.4816179431141e-05,0.000306846594719789,0.000185686290299419,"MAPK14/GRB2/MAPK11/MAPK12/RALA/SRC",6
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","6/99","20/2914",3.4816179431141e-05,0.000306846594719789,0.000185686290299419,"MAPK10/MAPK8/TRAF6/MAP2K4/MAPK9/MAP3K7",6
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","7/99","29/2914",3.56819348072705e-05,0.000310338932994814,0.000187799656880371,"E2F1/AKT1/TP53/MAPK8/AKT2/AKT3/TP73",7
"R-HSA-171007","R-HSA-171007","p38MAPK events","5/99","13/2914",4.24210055588727e-05,0.000364159541226167,0.000220368860046092,"MAPK14/MAPK11/MAPK12/RALA/SRC",5
"R-HSA-195721","R-HSA-195721","Signaling by WNT","17/99","172/2914",4.55291299725324e-05,0.000384030236886099,0.000232393486769197,"AP2M1/ARRB2/CTNNB1/AKT1/CREBBP/AXIN1/CSNK1A1/EP300/GSK3B/LRP6/HDAC1/PRKCB/PPP2CA/AKT2/MAP3K7/TCF7L2/NFATC1",17
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","12/99","92/2914",4.58977136369165e-05,0.000384030236886099,0.000232393486769197,"CTNNB1/VAV2/AKT1/PRKACA/MAPK14/MAPK11/MAPK12/PRKCD/PRKCB/SRC/AKT2/AKT3",12
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","7/99","31/2914",5.6845959811771e-05,0.000469689742944758,0.000284229799058855,"CTNNB1/AXIN1/CSNK1A1/GSK3B/LRP6/PPP2CA/TCF7L2",7
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","5/99","14/2914",6.42186499161097e-05,0.000487914110282167,0.000295258160533838,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","5/99","14/2914",6.42186499161097e-05,0.000487914110282167,0.000295258160533838,"CTNNB1/AXIN1/CSNK1A1/GSK3B/PPP2CA",5
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","5/99","14/2914",6.42186499161097e-05,0.000487914110282167,0.000295258160533838,"CTNNB1/AXIN1/CSNK1A1/GSK3B/PPP2CA",5
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","5/99","14/2914",6.42186499161097e-05,0.000487914110282167,0.000295258160533838,"CTNNB1/AXIN1/CSNK1A1/GSK3B/PPP2CA",5
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","5/99","14/2914",6.42186499161097e-05,0.000487914110282167,0.000295258160533838,"CTNNB1/AXIN1/CSNK1A1/GSK3B/PPP2CA",5
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","5/99","14/2914",6.42186499161097e-05,0.000487914110282167,0.000295258160533838,"CTNNB1/AXIN1/CSNK1A1/GSK3B/PPP2CA",5
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","5/99","14/2914",6.42186499161097e-05,0.000487914110282167,0.000295258160533838,"CTNNB1/AXIN1/CSNK1A1/GSK3B/PPP2CA",5
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","7/99","32/2914",7.07566447056166e-05,0.00053147888807287,0.000321621112298257,"MAPK1/MAPK3/TP53/ATF2/JUN/HDAC1/EGR1",7
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","6/99","24/2914",0.000108239317158563,0.000803889760020337,0.00048646884116208,"MAPK1/MAPK3/YAP1/RB1/AR/SRC",6
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","5/99","16/2914",0.000132705431280567,0.000974647667516166,0.000589801916802521,"CTNNB1/AXIN1/CSNK1A1/GSK3B/PPP2CA",5
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","8/99","47/2914",0.000140412774880924,0.0010199213647944,0.0006171990104656,"CREBBP/EP300/PPARGC1A/FHL2/NRF1/SREBF1/ESRRA/SP1",8
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","8/99","48/2914",0.000163821990685755,0.00117702538960091,0.000712269524720673,"CREBBP/EP300/PPARGC1A/FHL2/NRF1/SREBF1/ESRRA/SP1",8
"R-HSA-112316","R-HSA-112316","Neuronal System","12/99","105/2914",0.000170796432834204,0.00121233092430641,0.000733634447386633,"AP2M1/CAMK4/CAMKK2/MAPK1/MAPK3/PRKAA1/PRKAA2/CREB1/MDM2/PRKACA/PRKCB/SRC",12
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","17/99","191/2914",0.000172404095135859,0.00121233092430641,0.000733634447386633,"E2F1/AKT1/MAPK1/MAPK3/TP53/CDC25A/EP300/GSK3B/PRKACA/RB1/HDAC1/PRKCB/PPP2CA/SRC/AKT2/AKT3/JAK2",17
"R-HSA-111996","R-HSA-111996","Ca-dependent events","6/99","26/2914",0.000175193713759164,0.00121897941889271,0.000737657742143848,"CAMK4/CAMKK2/MAPK1/CREB1/PRKACA/PRKCD",6
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","7/99","37/2914",0.00018821218336472,0.00129591930420916,0.000784217430686333,"CTNNB1/AXIN1/CSNK1A1/GSK3B/HDAC1/PPP2CA/TCF7L2",7
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","10/99","77/2914",0.000214198076614682,0.00145575330256008,0.000880939971292031,"E2F1/AKT1/CDC25A/RB1/HDAC1/PPP2CA/SRC/AKT2/AKT3/JAK2",10
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","9/99","63/2914",0.000215830292966548,0.00145575330256008,0.000880939971292031,"EGFR/AKT1/MAPK1/MAPK3/CREB1/SRC/AKT2/AKT3/ELK1",9
"R-HSA-165159","R-HSA-165159","mTOR signalling","6/99","27/2914",0.000219114699515292,0.00146297794322837,0.000885311917233504,"AKT1/PRKAA1/PRKAA2/RPS6KB1/STK11/AKT2",6
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","12/99","108/2914",0.000224142514061115,0.00148158201794397,0.000896570056244461,"CTNNB1/AKT1/CREBBP/AXIN1/CSNK1A1/EP300/GSK3B/LRP6/HDAC1/PPP2CA/AKT2/TCF7L2",12
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","5/99","18/2914",0.000246559126811402,0.00161361963190432,0.000976471789352086,"EGFR/MAPK1/MAPK3/CREB1/GRB2",5
"R-HSA-400253","R-HSA-400253","Circadian Clock","8/99","52/2914",0.000291952782461452,0.00189196852163745,0.00114491287239785,"CREBBP/CREB1/EP300/ATF2/PPARGC1A/CREM/SREBF1/BHLHE40",8
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","10/99","80/2914",0.000295310852748071,0.0018951502297716,0.00114683826309931,"ARRB2/SMAD3/TP53/AXIN1/CDC25A/MDM2/MDM4/AR/TRAF6/MAP3K7",10
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","5/99","19/2914",0.000325667612340238,0.0020501551595895,0.00124063852320091,"AKT1/PPP2CA/SRC/AKT2/AKT3",5
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","5/99","19/2914",0.000325667612340238,0.0020501551595895,0.00124063852320091,"CREBBP/EP300/PRKACA/RPS6KA5/RELA",5
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","11/99","97/2914",0.000348077874778037,0.00217056108705927,0.00131350141425674,"EGFR/AKT1/CREB1/GSK3B/MDM2/GRB2/CHUK/GSK3A/SRC/AKT2/AKT3",11
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","6/99","30/2914",0.000404613082157908,0.00249952567576054,0.00151257226974919,"CTNNB1/AXIN1/CSNK1A1/GSK3B/LRP6/PPP2CA",6
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","11/99","99/2914",0.000416780431201493,0.0025508506020758,0.0015436312266722,"EGFR/AKT1/MAPK1/MAPK3/PHLPP1/TRAF6/GRB2/PPP2CA/SRC/AKT2/AKT3",11
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","8/99","56/2914",0.000492502754596394,0.00298664514484602,0.0018073495581519,"PRKAA1/PRKAA2/TP53/MDM2/MDM4/MAPK14/STK11/MAPK11",8
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","4/99","12/2914",0.000503242622176769,0.00302403066598949,0.00182997317155189,"MAPK1/MAPK3/DUSP7/PPP2CA",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","19/99","249/2914",0.0005224628701219,0.00311124285721239,0.00188274908152036,"E2F1/AKT1/MAPK1/MAPK3/TP53/CDC25A/EP300/GSK3B/MDM2/MDM4/PRKACA/RB1/HDAC1/PRKCB/PPP2CA/SRC/AKT2/AKT3/JAK2",19
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","10/99","86/2914",0.000535869192103196,0.00316258514268047,0.0019138185432257,"CREBBP/YAP1/AXIN1/EP300/MYB/HDAC1/PRKCB/SRC/TP73/SPI1",10
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","7/99","44/2914",0.000576260340564048,0.0033708680098481,0.0020398596126161,"EGFR/AKT1/GRB2/PRKCD/SRC/AKT2/AKT3",7
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","6/99","32/2914",0.000584381933093759,0.00338838998048223,0.002050462923136,"MAPK1/MAPK3/CREB1/RPS6KA5/GRB2/SRC",6
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","11/99","104/2914",0.000640002413086714,0.00367862256565494,0.00222609534986683,"ARRB2/E2F1/EGFR/AKT1/CREBBP/SMAD3/TP53/CREB1/EP300/JUN/HDAC1",11
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","5/99","22/2914",0.000680004131945839,0.00371446447413343,0.00224778485575397,"CTNNB1/CREBBP/EP300/HDAC1/TCF7L2",5
"R-HSA-525793","R-HSA-525793","Myogenesis","5/99","22/2914",0.000680004131945839,0.00371446447413343,0.00224778485575397,"CTNNB1/MAPK14/MAPK11/MAPK12/MEF2A",5
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","6/99","33/2914",0.00069483770680912,0.00371446447413343,0.00224778485575397,"MAPK14/TRAF6/MAPK11/MAPK12/CHUK/MAP3K7",6
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"AXIN1/CSNK1A1/GSK3B/PPP2CA",4
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"AXIN1/CSNK1A1/GSK3B/PPP2CA",4
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"AXIN1/CSNK1A1/GSK3B/PPP2CA",4
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"AXIN1/CSNK1A1/GSK3B/PPP2CA",4
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"AXIN1/CSNK1A1/GSK3B/PPP2CA",4
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"AXIN1/CSNK1A1/GSK3B/PPP2CA",4
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"TP53/EP300/MDM2/MDM4",4
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","4/99","13/2914",0.000708052229562499,0.00371446447413343,0.00224778485575397,"CREBBP/EP300/STK11/BCL6",4
"R-HSA-69206","R-HSA-69206","G1/S Transition","8/99","60/2914",0.000792852773781574,0.00412658018480016,0.00249717409065063,"E2F1/AKT1/CDC25A/RB1/HDAC1/PPP2CA/AKT2/AKT3",8
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","12/99","124/2914",0.000812953555020575,0.00417353089129582,0.00252558601591275,"ARRB2/SMAD3/TP53/AXIN1/CDC25A/EP300/MDM2/MDM4/AR/TRAF6/MAP3K7/YY1",12
"R-HSA-112040","R-HSA-112040","G-protein mediated events","6/99","34/2914",0.000820815455171644,0.00417353089129582,0.00252558601591275,"CAMK4/CAMKK2/MAPK1/CREB1/PRKACA/PRKCD",6
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","6/99","34/2914",0.000820815455171644,0.00417353089129582,0.00252558601591275,"CAMK4/CAMKK2/MAPK1/CREB1/PRKACA/PRKCD",6
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","5/99","23/2914",0.000845712296148061,0.0042672963950677,0.00258232762182614,"E2F1/CREBBP/TP53/EP300/JUN",5
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","6/99","35/2914",0.000963744088784386,0.00482602153550363,0.00292043663267996,"AKT1/PRKAA1/PRKAA2/TP53/AKT2/AKT3",6
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","7/99","48/2914",0.000990467681354722,0.00492254990507873,0.00297885016948789,"MAPK14/TRAF6/MAPK11/MAPK12/RELA/CHUK/MAP3K7",7
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","5/99","24/2914",0.00103978413272424,0.00512908441590093,0.00310383323201267,"AKT1/CREBBP/EP300/AKT2/AKT3",5
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","5/99","25/2914",0.00126509549122958,0.00610385488834126,0.00369370946344403,"CAMK4/CAMKK2/CREB1/PRKACA/PRKCD",5
"R-HSA-111997","R-HSA-111997","CaM pathway","5/99","25/2914",0.00126509549122958,0.00610385488834126,0.00369370946344403,"CAMK4/CAMKK2/CREB1/PRKACA/PRKCD",5
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","5/99","25/2914",0.00126509549122958,0.00610385488834126,0.00369370946344403,"CTNNB1/VAV2/AKT1/AKT2/AKT3",5
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","4/99","15/2914",0.00128261819650211,0.00614355527454996,0.00371773390290467,"CTNNB1/GRB2/SRC/SH3KBP1",4
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","6/99","39/2914",0.00173540949908246,0.00825255884096049,0.00499398417002148,"E2F1/AKT1/CDC25A/RB1/AKT2/AKT3",6
"R-HSA-422475","R-HSA-422475","Axon guidance","18/99","254/2914",0.0017872620222162,0.00839865817162399,0.0050823952627074,"AP2M1/EGFR/VAV2/MAPK1/MAPK3/CREB1/GSK3B/PRKACA/RPS6KA5/MAPK14/MAPK8/CXCR4/GRB2/MAPK11/MAPK12/SRC/RET/SH3KBP1",18
"R-HSA-373760","R-HSA-373760","L1CAM interactions","7/99","53/2914",0.00180425031826113,0.00839865817162399,0.0050823952627074,"AP2M1/EGFR/VAV2/MAPK1/MAPK3/RPS6KA5/SRC",7
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","7/99","53/2914",0.00180425031826113,0.00839865817162399,0.0050823952627074,"TRAF6/PRKCD/RELA/CHUK/SRC/MAP3K7/NFATC1",7
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","5/99","27/2914",0.00182129619055535,0.00841871875494466,0.00509453479875623,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","11/99","119/2914",0.00197712489432939,0.00899296938260767,0.00544203896073081,"CREBBP/PRKAA2/EP300/PRKACA/PPARGC1A/FHL2/PLD2/NRF1/SREBF1/ESRRA/SP1",11
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","6/99","40/2914",0.00198634422066675,0.00899296938260767,0.00544203896073081,"CREBBP/EP300/PPARGC1A/RELA/SREBF1/CEBPB",6
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","6/99","40/2914",0.00198634422066675,0.00899296938260767,0.00544203896073081,"E2F1/AKT1/CDC25A/RB1/AKT2/AKT3",6
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","5/99","28/2914",0.00215825594300447,0.00970481073691127,0.005872805287087,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","5/99","29/2914",0.00253857133927761,0.011174643371588,0.00676226527781421,"E2F1/CREBBP/TP53/EP300/JUN",5
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","6/99","42/2914",0.0025696608055694,0.011174643371588,0.00676226527781421,"ARRB2/MAPK1/MAPK3/PHB/SRC/JAK2",6
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","6/99","42/2914",0.0025696608055694,0.011174643371588,0.00676226527781421,"ARRB2/MAPK1/MAPK3/PHB/SRC/JAK2",6
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","6/99","42/2914",0.0025696608055694,0.011174643371588,0.00676226527781421,"ARRB2/MAPK1/MAPK3/PHB/SRC/JAK2",6
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","6/99","42/2914",0.0025696608055694,0.011174643371588,0.00676226527781421,"ARRB2/MAPK1/MAPK3/PHB/SRC/JAK2",6
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","5/99","30/2914",0.00296536299070156,0.0127279541354138,0.00770224153428976,"CAMK4/CAMKK2/CREB1/PRKACA/PRKCD",5
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","5/99","30/2914",0.00296536299070156,0.0127279541354138,0.00770224153428976,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","4/99","19/2914",0.00328010585189054,0.0139880643103203,0.00846478929520139,"SMAD3/PPARGC1A/HDAC1/SREBF1",4
"R-HSA-111885","R-HSA-111885","Opioid Signalling","7/99","59/2914",0.00338014451492594,0.0143222790023464,0.00866703721775881,"CAMK4/CAMKK2/MAPK1/CREB1/PRKACA/PRKCD/PPP2CA",7
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","5/99","31/2914",0.00344176410592858,0.0143987726203721,0.00871332685045211,"CTNNB1/AKT1/HDAC1/AKT2/TCF7L2",5
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","5/99","31/2914",0.00344176410592858,0.0143987726203721,0.00871332685045211,"AKT1/GRB2/SRC/AKT2/AKT3",5
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","6/99","45/2914",0.00367483464454376,0.0152771427675687,0.00924486703029876,"STAT3/MAPK1/MAPK3/JUN/RELA/CEBPB",6
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","3/99","10/2914",0.00383696306707737,0.0156557567119638,0.0094739828816725,"E2F1/RB1/PPP2CA",3
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","3/99","10/2914",0.00383696306707737,0.0156557567119638,0.0094739828816725,"CAMK4/CAMKK2/CREB1",3
"R-HSA-74749","R-HSA-74749","Signal attenuation","3/99","10/2914",0.00383696306707737,0.0156557567119638,0.0094739828816725,"MAPK1/MAPK3/GRB2",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","5/99","32/2914",0.00397090895274985,0.0159057218117827,0.0096252476924555,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","11/99","130/2914",0.00399007853277942,0.0159057218117827,0.0096252476924555,"CTNNB1/MAPK1/MAPK3/MAPK14/AR/GRB2/MAPK11/PRKCD/PRKCB/PPP2CA/SRC",11
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","4/99","20/2914",0.00399447779236903,0.0159057218117827,0.0096252476924555,"AP2M1/MAPK1/RPS6KA5/SRC",4
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/99","20/2914",0.00399447779236903,0.0159057218117827,0.0096252476924555,"EGFR/VAV2/MAPK1/MAPK3",4
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","7/99","62/2914",0.00448369993949739,0.0177468602395675,0.0107394010526884,"VAV2/MAPK1/MAPK3/GRB2/PRKCD/PLD2/SRC",7
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","5/99","33/2914",0.00455592167523927,0.0179253823055545,0.0108474325600935,"MAPK1/MAPK3/RB1/PRKCB/PPP2CA",5
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","4/99","21/2914",0.0048073267136257,0.0188026210515183,0.0113782880795874,"MAPK14/TRAF6/MAPK11/MAP3K7",4
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","7/99","63/2914",0.00490626129063907,0.019076698312426,0.0115441442132684,"GRB2/RELA/CHUK/PRKCB/SH3KBP1/MAP3K7/NFATC1",7
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/99","11/2914",0.00514666043962516,0.0193292190374558,0.0116969555446026,"E2F1/RB1/PPP2CA",3
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","3/99","11/2914",0.00514666043962516,0.0193292190374558,0.0116969555446026,"AKT1/AKT2/AKT3",3
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","3/99","11/2914",0.00514666043962516,0.0193292190374558,0.0116969555446026,"E2F1/CDC25A/HDAC1",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/99","11/2914",0.00514666043962516,0.0193292190374558,0.0116969555446026,"AKT1/AKT2/AKT3",3
"R-HSA-5099900","R-HSA-5099900","WNT5A-dependent internalization of FZD4","3/99","11/2914",0.00514666043962516,0.0193292190374558,0.0116969555446026,"AP2M1/ARRB2/PRKCB",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/99","11/2914",0.00514666043962516,0.0193292190374558,0.0116969555446026,"AKT1/AKT2/AKT3",3
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","5/99","34/2914",0.00519990550628541,0.019418856156241,0.0117511988842608,"CTNNB1/CREBBP/EP300/RELA/CHUK",5
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","6/99","49/2914",0.00565480796609599,0.0209990340763452,0.0127074336316764,"ARRB2/MAPK1/MAPK3/PHB/SRC/JAK2",6
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","4/99","22/2914",0.00572450950955456,0.0211391105352825,0.012792200021351,"CAMK4/CREB1/PRKACA/HDAC1",4
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","5/99","35/2914",0.00590593240920225,0.0216878962360149,0.0131242942426717,"MAPK14/MAPK8/MAPK11/MAPK12/SRC",5
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","8/99","82/2914",0.00596372483210763,0.0217791277017853,0.0131795023913981,"STAT3/SMAD3/MAPK8/TRAF6/MAP2K4/RELA/CHUK/MAP3K7",8
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","3/99","12/2914",0.00669446637877462,0.0237905498729571,0.0143967018898379,"MAPK1/MAPK3/CASP3",3
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","3/99","12/2914",0.00669446637877462,0.0237905498729571,0.0143967018898379,"CAMK4/CAMKK2/CREB1",3
"R-HSA-5635838","R-HSA-5635838","Activation of SMO","3/99","12/2914",0.00669446637877462,0.0237905498729571,0.0143967018898379,"ARRB2/CSNK1A1/SMO",3
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","3/99","12/2914",0.00669446637877462,0.0237905498729571,0.0143967018898379,"CAMK4/PRKACA/HDAC1",3
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","3/99","12/2914",0.00669446637877462,0.0237905498729571,0.0143967018898379,"CAMK4/PRKACA/HDAC1",3
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","4/99","23/2914",0.00675162471237698,0.0238653686357283,0.0144419779943893,"MAPK1/MAPK3/DUSP7/JAK2",4
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","5/99","37/2914",0.00751618800690818,0.0264265971945016,0.0159918893764004,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","4/99","24/2914",0.00789399282830753,0.0271767148932879,0.0164458183923074,"RELA/CHUK/PRKCB/MAP3K7",4
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","4/99","24/2914",0.00789399282830753,0.0271767148932879,0.0164458183923074,"TP53/CDC25A/MDM2/MDM4",4
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","4/99","24/2914",0.00789399282830753,0.0271767148932879,0.0164458183923074,"EGFR/AKT1/AKT2/AKT3",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/99","24/2914",0.00789399282830753,0.0271767148932879,0.0164458183923074,"STAT3/MAPK1/MAPK3/JAK2",4
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","6/99","53/2914",0.00832256532907037,0.0285037081995622,0.0172488400602495,"AKT1/GRB2/PPP2CA/SRC/AKT2/AKT3",6
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","5/99","38/2914",0.00842631758278771,0.0286334091946877,0.0173273278031393,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","3/99","13/2914",0.00849039062353827,0.0286334091946877,0.0173273278031393,"CREBBP/EP300/SREBF1",3
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/99","13/2914",0.00849039062353827,0.0286334091946877,0.0173273278031393,"AKT1/AKT2/AKT3",3
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","11/99","144/2914",0.00863329353965474,0.0289675483741715,0.0175295300297558,"AP2M1/ARRB2/EGFR/AKT1/PRKAA2/GRB2/RALA/SRC/AKT2/AKT3/SH3KBP1",11
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","4/99","25/2914",0.0091566399401319,0.0304147688463678,0.0184053064123254,"ARRB2/MAPK1/MAPK3/SRC",4
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","4/99","25/2914",0.0091566399401319,0.0304147688463678,0.0184053064123254,"EGFR/CREBBP/EP300/YY1",4
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","5/99","39/2914",0.00941027465392084,0.0309724417697137,0.0187427786806134,"RELA/CHUK/PRKCB/MAP3K7/NFATC1",5
"R-HSA-69242","R-HSA-69242","S Phase","7/99","71/2914",0.00945089558675685,0.0309724417697137,0.0187427786806134,"E2F1/AKT1/CDC25A/GSK3B/RB1/AKT2/AKT3",7
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","9/99","107/2914",0.00946510323370979,0.0309724417697137,0.0187427786806134,"CREBBP/TP53/EP300/MDM2/PPARGC1A/AR/DAXX/HDAC1/RELA",9
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","5/99","40/2914",0.0104708361443857,0.0336703957868546,0.0203754286153432,"E2F1/RB1/PPP2CA/SRC/JAK2",5
"R-HSA-69236","R-HSA-69236","G1 Phase","5/99","40/2914",0.0104708361443857,0.0336703957868546,0.0203754286153432,"E2F1/RB1/PPP2CA/SRC/JAK2",5
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","3/99","14/2914",0.0105426101586611,0.0336703957868546,0.0203754286153432,"CREBBP/SREBF1/SP1",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","4/99","26/2914",0.0105442843084401,0.0336703957868546,0.0203754286153432,"AKT1/PRKAA2/RALA/AKT2",4
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","4/99","26/2914",0.0105442843084401,0.0336703957868546,0.0203754286153432,"GSK3B/PPARGC1A/TWIST1/ESRRA",4
"R-HSA-2990846","R-HSA-2990846","SUMOylation","9/99","109/2914",0.010640308416471,0.0338136724196507,0.0204621315701366,"CREBBP/TP53/EP300/MDM2/PPARGC1A/AR/DAXX/HDAC1/RELA",9
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","5/99","41/2914",0.0116106957838709,0.0367209086753046,0.0222214273375519,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","8/99","92/2914",0.0117822769325956,0.0370861192973604,0.022442432252563,"EGFR/AKT1/MAPK1/MAPK3/TRAF6/GRB2/PPP2CA/SRC",8
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","4/99","27/2914",0.0120613257202461,0.0372548425284238,0.0225445340565348,"TRAF6/RELA/CHUK/MAP3K7",4
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","4/99","27/2914",0.0120613257202461,0.0372548425284238,0.0225445340565348,"CREBBP/EP300/JUN/YY1",4
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","4/99","27/2914",0.0120613257202461,0.0372548425284238,0.0225445340565348,"CREBBP/EP300/JUN/YY1",4
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","4/99","27/2914",0.0120613257202461,0.0372548425284238,0.0225445340565348,"YAP1/MYB/TP73/SPI1",4
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/99","15/2914",0.0128576081492009,0.0389856834248705,0.0235919415581667,"AKT1/AKT2/AKT3",3
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","3/99","15/2914",0.0128576081492009,0.0389856834248705,0.0235919415581667,"EP300/GSK3B/HDAC1",3
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","3/99","15/2914",0.0128576081492009,0.0389856834248705,0.0235919415581667,"CREBBP/TP53/TP73",3
"R-HSA-69541","R-HSA-69541","Stabilization of p53","3/99","15/2914",0.0128576081492009,0.0389856834248705,0.0235919415581667,"TP53/MDM2/MDM4",3
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","7/99","76/2914",0.0135329129677981,0.0408459153959569,0.0247176492562523,"AP2M1/ARRB2/CTNNB1/PRKCB/MAP3K7/TCF7L2/NFATC1",7
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","3/99","16/2914",0.0154403048486528,0.0459426417106737,0.0278019011864894,"MAPK1/MAPK3/CASP3",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/99","16/2914",0.0154403048486528,0.0459426417106737,0.0278019011864894,"AKT1/AKT2/AKT3",3
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","3/99","16/2914",0.0154403048486528,0.0459426417106737,0.0278019011864894,"EP300/MDM2/SRC",3
"R-HSA-5673000","R-HSA-5673000","RAF activation","4/99","29/2914",0.0154995599114678,0.0459426417106737,0.0278019011864894,"PHB/PPP2CA/SRC/JAK2",4
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","4/99","30/2914",0.017427897899278,0.0514278594259945,0.0311212462487108,"CREBBP/TP53/TP73/BCL6",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","13/99","202/2914",0.0175306358350496,0.0515011123865234,0.0311655748178659,"ARRB2/EGFR/MAPK1/MAPK3/PRKACA/DUSP7/JUN/GRB2/PHB/PPP2CA/SRC/RET/JAK2",13
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","11/99","160/2914",0.0182083402502128,0.0525758850568749,0.0318159667515128,"AP2M1/ARRB2/EGFR/AKT1/PRKAA2/GRB2/RALA/SRC/AKT2/AKT3/SH3KBP1",11
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","3/99","17/2914",0.0182941808821199,0.0525758850568749,0.0318159667515128,"EGFR/GRB2/SRC",3
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","3/99","17/2914",0.0182941808821199,0.0525758850568749,0.0318159667515128,"AP2M1/MDM2/PRKCB",3
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","3/99","17/2914",0.0182941808821199,0.0525758850568749,0.0318159667515128,"AP2M1/MDM2/PRKCB",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/99","17/2914",0.0182941808821199,0.0525758850568749,0.0318159667515128,"CREBBP/SMAD3/EP300",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","5/99","46/2914",0.0185871054879412,0.0531864793399531,0.0321854640483831,"ARRB2/MAPK1/MAPK3/SRC/JAK2",5
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","4/99","31/2914",0.019499917720515,0.0555579552295706,0.0336205477939913,"AKT1/MAPK14/MAPK11/PRKCD",4
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","3/99","18/2914",0.0214213932877258,0.0605108588170373,0.0366177663038047,"PRKAA1/PRKAA2/STK11",3
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","3/99","18/2914",0.0214213932877258,0.0605108588170373,0.0366177663038047,"CSNK1A1/GSK3B/PRKACA",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","4/99","32/2914",0.0217183475444814,0.060829778503823,0.0368107585499685,"ARRB2/MAPK1/MAPK3/SRC",4
"R-HSA-8853659","R-HSA-8853659","RET signaling","4/99","32/2914",0.0217183475444814,0.060829778503823,0.0368107585499685,"PRKACA/GRB2/SRC/RET",4
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","12/99","188/2914",0.0236078301099401,0.0658429354543054,0.0398444390041182,"ARRB2/EGFR/MAPK1/MAPK3/DUSP7/GRB2/PHB/PPP2CA/SRC/AKT2/RET/JAK2",12
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","5/99","49/2914",0.0238751664782235,0.0663087606811165,0.0401263302155017,"CREBBP/MAPK1/MAPK3/EP300/GSK3B",5
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/99","19/2914",0.0248228846819449,0.0680826837127202,0.0411998086007384,"E2F1/CDC25A/HDAC1",3
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","3/99","19/2914",0.0248228846819449,0.0680826837127202,0.0411998086007384,"PRKCD/PRKCB/SRC",3
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","3/99","19/2914",0.0248228846819449,0.0680826837127202,0.0411998086007384,"CSNK1A1/GSK3B/PRKACA",3
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","5/99","50/2914",0.0258332278874577,0.0703524636983901,0.0425733517085568,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","8/99","106/2914",0.0258633111629482,0.0703524636983901,0.0425733517085568,"VAV2/MAPK8/CASP3/TRAF6/HDAC1/RELA/CHUK/MAP3K7",8
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/99","68/2914",0.0263924009260493,0.0714838408563079,0.0432579974924708,"E2F1/TP53/CDC25A/EP300/PRKACA/PPP2CA",6
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","4/99","34/2914",0.0266036684578695,0.0714838408563079,0.0432579974924708,"ARRB2/MAPK1/MAPK3/SRC",4
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","4/99","34/2914",0.0266036684578695,0.0714838408563079,0.0432579974924708,"MAPK1/MAPK3/DUSP7/PPP2CA",4
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","11/99","171/2914",0.0283757094012679,0.0759366150374011,0.0459525658320128,"ARRB2/EGFR/MAPK1/MAPK3/DUSP7/GRB2/PHB/PPP2CA/SRC/RET/JAK2",11
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","3/99","20/2914",0.0284984858977524,0.0759576579774771,0.0459652998350845,"CREBBP/SREBF1/SP1",3
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","4/99","35/2914",0.0292743440770524,0.077712214598119,0.0470270587583171,"CSNK1A1/GSK3B/PRKACA/SMO",4
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","5/99","53/2914",0.0323155120709852,0.0844388787999958,0.0510976573676222,"AP2M1/ARRB2/EGFR/GRB2/SH3KBP1",5
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","3/99","21/2914",0.0324470124284401,0.0844388787999958,0.0510976573676222,"CTNNB1/CASP3/PRKCD",3
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/99","21/2914",0.0324470124284401,0.0844388787999958,0.0510976573676222,"AKT1/AKT2/AKT3",3
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","3/99","21/2914",0.0324470124284401,0.0844388787999958,0.0510976573676222,"AKT1/AKT2/AKT3",3
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","3/99","21/2914",0.0324470124284401,0.0844388787999958,0.0510976573676222,"TRAF6/RELA/CHUK",3
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","10/99","153/2914",0.0327584733809418,0.084915101587461,0.0513858405975558,"ARRB2/VAV2/AKT1/MAPK1/MAPK3/MAPK14/GRB2/PRKCD/PRKCB/SRC",10
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","4/99","37/2914",0.0350787436890707,0.0905744124159208,0.0548105370141729,"CREBBP/EP300/PPARGC1A/DAXX",4
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","11/99","177/2914",0.0354064235866829,0.0910647703922079,0.0551072740648762,"ARRB2/EGFR/MAPK1/MAPK3/DUSP7/GRB2/PHB/PPP2CA/SRC/RET/JAK2",11
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","3/99","22/2914",0.03666635499458,0.092860002495852,0.056193647501272,"EGFR/GRB2/PRKCD",3
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/99","22/2914",0.03666635499458,0.092860002495852,0.056193647501272,"MAPK1/MAPK3/CREB1",3
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","3/99","22/2914",0.03666635499458,0.092860002495852,0.056193647501272,"TP53/MDM2/MDM4",3
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","3/99","22/2914",0.03666635499458,0.092860002495852,0.056193647501272,"TP53/MDM2/MDM4",3
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","5/99","55/2914",0.0371565298013019,0.0933858030367321,0.0565118323974173,"MAPK1/MAPK3/GRB2/PPP2CA/SRC",5
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","5/99","55/2914",0.0371565298013019,0.0933858030367321,0.0565118323974173,"ARRB2/CSNK1A1/GSK3B/PRKACA/SMO",5
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","4/99","38/2914",0.0382143232309863,0.0956805593018256,0.0579004897439187,"TRAF6/RELA/CHUK/MAP3K7",4
"R-HSA-109582","R-HSA-109582","Hemostasis","16/99","298/2914",0.0409593335907706,0.10216648869245,0.061825409193616,"ARRB2/VAV2/AKT1/MAPK1/MAPK3/TP53/PRKACA/MAPK14/MYB/GRB2/PRKCD/HDAC1/PRKCB/PPP2CA/SRC/JAK2",16
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","5/99","57/2914",0.0424225463044568,0.103094139185032,0.0623867710650721,"TRAF6/MAP2K4/RELA/CHUK/MAP3K7",5
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","6/99","76/2914",0.0424737373971677,0.103094139185032,0.0623867710650721,"VAV2/MAPK8/CASP3/TRAF6/HDAC1/RELA",6
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"MAPK3/JAK2",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"MAPK1/MAPK3",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"E2F1/HDAC1",2
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"TRAF6/RELA",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"EP300/GSK3B",2
"R-HSA-8875360","R-HSA-8875360","InlB-mediated entry of Listeria monocytogenes into host cell","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"GRB2/SH3KBP1",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"STAT3/JAK2",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"CREBBP/EP300",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/99","10/2914",0.0430468720348997,0.103094139185032,0.0623867710650721,"MAPK1/MAPK3",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","4/99","40/2914",0.0449545898694423,0.106888431308278,0.0646828631214997,"CTNNB1/MAP3K7/TCF7L2/NFATC1",4
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","4/99","40/2914",0.0449545898694423,0.106888431308278,0.0646828631214997,"AKT1/CREBBP/SMAD3/EP300",4
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","3/99","24/2914",0.0459049319238538,0.108756845884112,0.0658135224714749,"SMAD3/HDAC1/SP1",3
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","4/99","41/2914",0.0485593351759906,0.114226763527864,0.0691236087914458,"STAT3/GRB2/SRC/JAK2",4
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","4/99","41/2914",0.0485593351759906,0.114226763527864,0.0691236087914458,"CAMK4/CREB1/PRKACA/HDAC1",4
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","3/99","25/2914",0.0509160626489067,0.11493615670592,0.0695528936193163,"AKT1/GRB2/SRC",3
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/99","25/2914",0.0509160626489067,0.11493615670592,0.0695528936193163,"MAPK1/MAPK3/GRB2",3
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","3/99","25/2914",0.0509160626489067,0.11493615670592,0.0695528936193163,"AKT1/AKT2/AKT3",3
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","3/99","25/2914",0.0509160626489067,0.11493615670592,0.0695528936193163,"AKT1/GRB2/SRC",3
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/99","25/2914",0.0509160626489067,0.11493615670592,0.0695528936193163,"AKT1/AKT2/AKT3",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"STAT3/JAK2",2
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"TRAF6/RELA",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"CREB1/EP300",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"STAT3/JAK2",2
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"CREBBP/EP300",2
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"ATF3/CEBPB",2
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"TP53/TP73",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"E2F1/TP53",2
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"EGFR/YY1",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/99","11/2914",0.0514691412782941,0.11493615670592,0.0695528936193163,"STAT3/JAK2",2
"R-HSA-182971","R-HSA-182971","EGFR downregulation","3/99","26/2914",0.0561819467802718,0.123906881145657,0.0749814711925308,"EGFR/GRB2/SH3KBP1",3
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","3/99","26/2914",0.0561819467802718,0.123906881145657,0.0749814711925308,"CTNNB1/CASP3/PRKCD",3
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","4/99","43/2914",0.0562361033943981,0.123906881145657,0.0749814711925308,"TRAF6/RELA/CHUK/MAP3K7",4
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","4/99","43/2914",0.0562361033943981,0.123906881145657,0.0749814711925308,"VAV2/MAPK1/MAPK3/GRB2",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","5/99","62/2914",0.0574787925120924,0.126224192194329,0.0763837774247076,"TP53/PRKACA/MYB/HDAC1/JAK2",5
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","4/99","44/2914",0.0603065524314214,0.127604838359964,0.0772192667836396,"EGFR/YAP1/GRB2/SRC",4
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","4/99","44/2914",0.0603065524314214,0.127604838359964,0.0772192667836396,"EGFR/GRB2/SRC/SH3KBP1",4
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"MAPK1/MAPK3",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"STAT3/GRB2",2
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"YAP1/TEAD4",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"CREBBP/EP300",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"CTNNB1/TCF7L2",2
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"CREB1/PRKACA",2
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"CREB1/HDAC1",2
"R-HSA-937039","R-HSA-937039","IRAK1 recruits IKK complex","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"TRAF6/CHUK",2
"R-HSA-975144","R-HSA-975144","IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"TRAF6/CHUK",2
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","2/99","12/2914",0.060424076258198,0.127604838359964,0.0772192667836396,"TRAF6/MAP3K7",2
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","3/99","28/2914",0.0674552468603337,0.141548946586288,0.0856574563305825,"CREBBP/SREBF1/SP1",3
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","3/99","28/2914",0.0674552468603337,0.141548946586288,0.0856574563305825,"CREBBP/EP300/TRAF6",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"CREB1/PRKACA",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"MAPK1/MAPK3",2
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"EGFR/GRB2",2
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"TRAF6/RELA",2
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"MAPK8/TRAF6",2
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"GRB2/SRC",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"CREBBP/EP300",2
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","2/99","13/2914",0.0698665645554088,0.142977706412152,0.0865220613689273,"TRAF6/MAP3K7",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","5/99","66/2914",0.0714809524000466,0.144935305326475,0.0877066900614069,"CREBBP/EP300/TRAF6/RELA/CHUK",5
"R-HSA-69275","R-HSA-69275","G2/M Transition","5/99","66/2914",0.0714809524000466,0.144935305326475,0.0877066900614069,"TP53/CDC25A/EP300/PRKACA/PPP2CA",5
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","5/99","66/2914",0.0714809524000466,0.144935305326475,0.0877066900614069,"AP2M1/ARRB2/EGFR/GRB2/SH3KBP1",5
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","15/99","296/2914",0.0717542554747372,0.145044534766976,0.0877727895715439,"AP2M1/AKT1/PRKACA/TRAF6/GRB2/RELA/CHUK/PRKCB/PPP2CA/SRC/AKT2/AKT3/SH3KBP1/MAP3K7/NFATC1",15
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","3/99","29/2914",0.0734501338159721,0.147122843795023,0.0890304652314813,"STAT3/GRB2/SRC",3
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","3/99","29/2914",0.0734501338159721,0.147122843795023,0.0890304652314813,"VAV2/GRB2/NFATC1",3
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","3/99","29/2914",0.0734501338159721,0.147122843795023,0.0890304652314813,"GSK3A/ATF3/CEBPB",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/99","30/2914",0.0796748266956047,0.155050945530883,0.093828106221412,"E2F1/TP53/EP300",3
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"EGFR/GRB2",2
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"ATF3/CEBPB",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"CTNNB1/TCF7L2",2
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"EGFR/GRB2",2
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"EGFR/GRB2",2
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"MAP2K4/CHUK",2
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"STAT3/GRB2",2
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"GRB2/JAK2",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/99","14/2914",0.0797538902882002,0.155050945530883,0.093828106221412,"CREBBP/EP300",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","12/99","228/2914",0.0821984157301752,0.159334758937378,0.0964204290090031,"CTNNB1/VAV2/MAPK1/MAPK3/MAPK14/AR/GRB2/MAPK11/PRKCD/PRKCB/PPP2CA/SRC",12
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"GRB2/SRC",2
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"YAP1/CASP3",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"MAPK14/PPP2CA",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"TP53/EP300",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"E2F1/HDAC1",2
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"CDC25A/JUN",2
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"CDC25A/JUN",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/99","15/2914",0.0900456260018923,0.170544867585246,0.103204155876094,"STAT3/SMAD3",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/99","32/2914",0.0927845994915445,0.174731111862994,0.105737435317999,"MAPK1/MAPK3/GSK3B",3
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","3/99","32/2914",0.0927845994915445,0.174731111862994,0.105737435317999,"STAT3/RALA/JAK2",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","6/99","94/2914",0.0977005644123006,0.182870968914069,0.110663218707455,"STAT3/AKT1/TP53/JAK2/TWIST1/BCL6",6
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","4/99","52/2914",0.0982425067431583,0.182870968914069,0.110663218707455,"MAPK1/MAPK3/GRB2/AKT2",4
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","4/99","52/2914",0.0982425067431583,0.182870968914069,0.110663218707455,"MAPK1/MAPK3/GRB2/AKT2",4
"R-HSA-5632684","R-HSA-5632684","Hedgehog 'on' state","3/99","33/2914",0.0996545015708129,0.182870968914069,0.110663218707455,"ARRB2/CSNK1A1/SMO",3
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","3/99","33/2914",0.0996545015708129,0.182870968914069,0.110663218707455,"AKT1/GRB2/SRC",3
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"EGFR/GRB2",2
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"RELA/CHUK",2
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"EGFR/GRB2",2
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"EGFR/GRB2",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"TP53/MDM2",2
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"EGFR/GRB2",2
"R-HSA-6807004","R-HSA-6807004","Negative regulation of MET activity","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"GRB2/SH3KBP1",2
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","2/99","16/2914",0.100703529023784,0.182870968914069,0.110663218707455,"GRB2/SRC",2
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","3/99","34/2914",0.106723937033356,0.192744596664066,0.116638182550116,"CREBBP/EP300/ATF2",3
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/99","34/2914",0.106723937033356,0.192744596664066,0.116638182550116,"TP53/ATF2/JUN",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","14/99","289/2914",0.107306873369914,0.193269327786139,0.116955720294184,"AKT1/CREBBP/PRKAA2/EP300/PRKACA/PPARGC1A/STK11/FHL2/PLD2/PPP2CA/NRF1/SREBF1/ESRRA/SP1",14
"R-HSA-168927","R-HSA-168927","TICAM1, RIP1-mediated IKK complex recruitment","2/99","17/2914",0.111691442109339,0.198997421116639,0.120422040010069,"TRAF6/CHUK",2
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","2/99","17/2914",0.111691442109339,0.198997421116639,0.120422040010069,"PRKCD/PLD2",2
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","2/99","17/2914",0.111691442109339,0.198997421116639,0.120422040010069,"MAPK14/SRC",2
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","2/99","17/2914",0.111691442109339,0.198997421116639,0.120422040010069,"RELA/CHUK",2
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","4/99","55/2914",0.114785309192114,0.203959917677386,0.123425063647435,"PRKAA2/PRKACA/STK11/PPP2CA",4
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/99","36/2914",0.121429002594224,0.215186516661614,0.130218769538042,"SMAD3/HDAC1/SP1",3
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/99","18/2914",0.12297519821204,0.21676428271509,0.13117354475951,"CDC25A/PPP2CA",2
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","2/99","18/2914",0.12297519821204,0.21676428271509,0.13117354475951,"CREBBP/EP300",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","3/99","37/2914",0.129048143085855,0.226262128858754,0.136921106722393,"EP300/GSK3B/HDAC1",3
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/99","37/2914",0.129048143085855,0.226262128858754,0.136921106722393,"EGFR/CREBBP/EP300",3
"R-HSA-5663205","R-HSA-5663205","Infectious disease","7/99","126/2914",0.133764278378902,0.233384230476376,0.141231001801135,"AP2M1/CTNNB1/CXCR4/GRB2/MAP2K4/SRC/SH3KBP1",7
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","2/99","19/2914",0.134522529215581,0.233384230476376,0.141231001801135,"CREBBP/BHLHE40",2
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","2/99","19/2914",0.134522529215581,0.233384230476376,0.141231001801135,"RELA/CHUK",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","2/99","19/2914",0.134522529215581,0.233384230476376,0.141231001801135,"CREBBP/EP300",2
"R-HSA-202403","R-HSA-202403","TCR signaling","4/99","59/2914",0.13860787086923,0.239842415299899,0.145139131800241,"TRAF6/RELA/CHUK/MAP3K7",4
"R-HSA-68886","R-HSA-68886","M Phase","6/99","105/2914",0.14430877351101,0.246071930714328,0.148908883942104,"MAPK1/MAPK3/PRKACA/RB1/PRKCB/PPP2CA",6
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","19/99","436/2914",0.145650559567643,0.246071930714328,0.148908883942104,"ARRB2/EGFR/VAV2/AKT1/CAMK4/CAMKK2/MAPK1/MAPK3/CREB1/PRKACA/CXCR4/GRB2/GRK6/PRKCD/PRKCB/PPP2CA/SRC/AKT2/AKT3",19
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"SMAD3/HDAC1",2
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"RELA/CHUK",2
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"RELA/CHUK",2
"R-HSA-70171","R-HSA-70171","Glycolysis","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"PRKACA/PPP2CA",2
"R-HSA-70326","R-HSA-70326","Glucose metabolism","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"PRKACA/PPP2CA",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"MAPK3/HDAC1",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"MAPK3/HDAC1",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"EP300/HDAC1",2
"R-HSA-937041","R-HSA-937041","IKK complex recruitment mediated by RIP1","2/99","20/2914",0.146302978473118,0.246071930714328,0.148908883942104,"TRAF6/CHUK",2
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","4/99","61/2914",0.151214607156227,0.253687450076817,0.153517367671296,"VAV2/MAPK8/CASP3/TRAF6",4
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","3/99","40/2914",0.152871652484231,0.255818132385004,0.154806736692892,"CREBBP/EP300/HDAC1",3
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","4/99","62/2914",0.157679146097201,0.26319675649053,0.159271864744648,"STAT3/GRB2/SRC/SH3KBP1",4
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","3/99","41/2914",0.161106835429618,0.268240851936972,0.162324267435384,"STAT3/GRB2/JAK2",3
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","6/99","109/2914",0.163437927355766,0.27075807013073,0.163847546221319,"CREBBP/EP300/ATF2/HDAC1/RELA/JAK2",6
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","6/99","109/2914",0.163437927355766,0.27075807013073,0.163847546221319,"CREBBP/EP300/ATF2/HDAC1/RELA/JAK2",6
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","3/99","42/2914",0.16947504898833,0.278879766531103,0.168762339807022,"AP2M1/VAV2/SRC",3
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","2/99","22/2914",0.170449963205092,0.278879766531103,0.168762339807022,"EGFR/GRB2",2
"R-HSA-180024","R-HSA-180024","DARPP-32 events","2/99","22/2914",0.170449963205092,0.278879766531103,0.168762339807022,"PRKACA/PPP2CA",2
"R-HSA-5357956","R-HSA-5357956","TNFR1-induced NFkappaB signaling pathway","2/99","22/2914",0.170449963205092,0.278879766531103,0.168762339807022,"CHUK/MAP3K7",2
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","2/99","22/2914",0.170449963205092,0.278879766531103,0.168762339807022,"EP300/SREBF1",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","4/99","64/2914",0.170911654397624,0.278944700140319,0.168801633972962,"ARRB2/CREBBP/EP300/HDAC1",4
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","17/99","393/2914",0.171680382305318,0.279509193851762,0.169143233798343,"ARRB2/CREBBP/SMAD3/TP53/AXIN1/CDC25A/EP300/MDM2/MDM4/PPARGC1A/AR/TRAF6/DAXX/HDAC1/RELA/MAP3K7/YY1",17
"R-HSA-392518","R-HSA-392518","Signal amplification","2/99","23/2914",0.182763905935395,0.29537149590048,0.178742206293785,"MAPK14/SRC",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/99","23/2914",0.182763905935395,0.29537149590048,0.178742206293785,"STAT3/JAK2",2
"R-HSA-9020591","R-HSA-9020591","Interleukin-12 signaling","2/99","23/2914",0.182763905935395,0.29537149590048,0.178742206293785,"RALA/JAK2",2
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","3/99","44/2914",0.186577341918347,0.300799080507385,0.18202667504229,"AP2M1/ARRB2/PRKCB",3
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","2/99","24/2914",0.195205630845535,0.308827726180562,0.186885159564637,"CREBBP/EP300",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/99","24/2914",0.195205630845535,0.308827726180562,0.186885159564637,"STAT3/GRB2",2
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","2/99","24/2914",0.195205630845535,0.308827726180562,0.186885159564637,"VAV2/GRB2",2
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","2/99","24/2914",0.195205630845535,0.308827726180562,0.186885159564637,"VAV2/GRB2",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/99","24/2914",0.195205630845535,0.308827726180562,0.186885159564637,"TP53/RB1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/99","24/2914",0.195205630845535,0.308827726180562,0.186885159564637,"STAT3/JAK2",2
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","2/99","24/2914",0.195205630845535,0.308827726180562,0.186885159564637,"GRB2/JAK2",2
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","3/99","45/2914",0.195294991745045,0.308827726180562,0.186885159564637,"PRKACA/GRB2/JAK2",3
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","20/99","486/2914",0.203418749360627,0.32090642798896,0.194194510129476,"ARRB2/EGFR/VAV2/AKT1/CAMK4/CAMKK2/MAPK1/MAPK3/CREB1/PRKACA/SMO/CXCR4/GRB2/GRK6/PRKCD/PRKCB/PPP2CA/SRC/AKT2/AKT3",20
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/99","46/2914",0.204112843631081,0.321234737238439,0.194393184410553,"AR/NR2C2/ESRRA",3
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","2/99","25/2914",0.207752549819155,0.326186307435775,0.197389596027701,"GRB2/SRC",2
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/99","47/2914",0.213022932461531,0.332879806990714,0.201440125259131,"EGFR/STAT3/AKT1",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/99","47/2914",0.213022932461531,0.332879806990714,0.201440125259131,"EGFR/STAT3/AKT1",3
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","2/99","26/2914",0.220383433405728,0.342761057602792,0.207419702028921,"CREBBP/HDAC1",2
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","2/99","26/2914",0.220383433405728,0.342761057602792,0.207419702028921,"GRB2/JAK2",2
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","3/99","49/2914",0.231088583351842,0.358290201834265,0.216817066162944,"STAT3/GRB2/SRC",3
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/99","27/2914",0.233078346125165,0.358290201834265,0.216817066162944,"YAP1/SRC",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/99","27/2914",0.233078346125165,0.358290201834265,0.216817066162944,"TP53/TRAF6",2
"R-HSA-75893","R-HSA-75893","TNF signaling","2/99","27/2914",0.233078346125165,0.358290201834265,0.216817066162944,"CHUK/MAP3K7",2
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","2/99","27/2914",0.233078346125165,0.358290201834265,0.216817066162944,"GRB2/SH3KBP1",2
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","3/99","51/2914",0.24943085510194,0.379020218902028,0.229361705840864,"CREBBP/EP300/HDAC1",3
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","3/99","51/2914",0.24943085510194,0.379020218902028,0.229361705840864,"CREBBP/EP300/HDAC1",3
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","3/99","51/2914",0.24943085510194,0.379020218902028,0.229361705840864,"CREBBP/EP300/HDAC1",3
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","3/99","51/2914",0.24943085510194,0.379020218902028,0.229361705840864,"CREBBP/EP300/HDAC1",3
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","3/99","51/2914",0.24943085510194,0.379020218902028,0.229361705840864,"CREBBP/EP300/HDAC1",3
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/99","29/2914",0.258586617916387,0.391134449525703,0.236692556445206,"CREB1/EP300",2
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","2/99","29/2914",0.258586617916387,0.391134449525703,0.236692556445206,"PRKCD/PRKCB",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","3/99","53/2914",0.267991063535295,0.404434002275868,0.244740697292507,"PRKAA1/PRKAA2/SRC",3
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/99","30/2914",0.271366031575014,0.408594412007026,0.247258343120742,"STAT3/TP53",2
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","2/99","31/2914",0.284141472485602,0.424926500708105,0.257141604059368,"AP2M1/PRKACA",2
"R-HSA-391251","R-HSA-391251","Protein folding","2/99","31/2914",0.284141472485602,0.424926500708105,0.257141604059368,"STAT3/TP53",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/99","31/2914",0.284141472485602,0.424926500708105,0.257141604059368,"STAT3/GRB2",2
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"PRKCD",1
"R-HSA-164938","R-HSA-164938","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"AP2M1",1
"R-HSA-2025928","R-HSA-2025928","Calcineurin activates NFAT","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"NFATC1",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"SRC",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"GSK3A",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"RELA",1
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"GRB2",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"SRC",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/99","10/2914",0.292621054512626,0.428874760604979,0.25953086874734,"STAT3",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","3/99","57/2914",0.30554384977799,0.444506705939777,0.268990442323617,"CTNNB1/GRB2/SRC",3
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","5/99","109/2914",0.311097839711366,0.444506705939777,0.268990442323617,"AKT1/MAPK14/MAPK11/PRKCD/PPP2CA",5
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","9/99","217/2914",0.315410222909336,0.444506705939777,0.268990442323617,"CAMK4/CAMKK2/MAPK1/CREB1/PRKACA/CXCR4/PRKCD/PPP2CA/SRC",9
"R-HSA-163615","R-HSA-163615","PKA activation","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"PRKACA",1
"R-HSA-209543","R-HSA-209543","p75NTR recruits signalling complexes","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"TRAF6",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"SRC",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"TP53",1
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"SRC",1
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"STAT3",1
"R-HSA-5210891","R-HSA-5210891","Uptake and function of anthrax toxins","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"MAP2K4",1
"R-HSA-5607763","R-HSA-5607763","CLEC7A (Dectin-1) induces NFAT activation","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"NFATC1",1
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"GRB2",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"CDC25A",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"CDC25A",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"CDC25A",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"GSK3B",1
"R-HSA-8875555","R-HSA-8875555","MET activates RAP1 and RAC1","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"GRB2",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"PRKAA2",1
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"JAK2",1
"R-HSA-9028731","R-HSA-9028731","Activated NTRK2 signals through FRS2 and FRS3","1/99","11/2914",0.316736245836059,0.444506705939777,0.268990442323617,"GRB2",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/99","34/2914",0.322305278251932,0.450409701743187,0.272562603172882,"PRKACA/JUN",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/99","34/2914",0.322305278251932,0.450409701743187,0.272562603172882,"TP53/MAPK8",2
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/99","35/2914",0.334930759577928,0.462478785552741,0.279866133466106,"TP53/MAPK8",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"PLD2",1
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"SMAD3",1
"R-HSA-162594","R-HSA-162594","Early Phase of HIV Life Cycle","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"CXCR4",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"GSK3A",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"GRB2",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"CTNNB1",1
"R-HSA-5620920","R-HSA-5620920","Cargo trafficking to the periciliary membrane","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"SMO",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"RELA",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"PRKACA",1
"R-HSA-8964043","R-HSA-8964043","Plasma lipoprotein clearance","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"AP2M1",1
"R-HSA-933543","R-HSA-933543","NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"CHUK",1
"R-HSA-975110","R-HSA-975110","TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","1/99","12/2914",0.340037352161319,0.462478785552741,0.279866133466106,"TRAF6",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","3/99","61/2914",0.34333262380832,0.466001774819917,0.281998048302522,"PRKAA1/PRKAA2/SRC",3
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","5/99","114/2914",0.345253714449955,0.467648986170943,0.282994847909799,"TP53/CDC25A/MDM2/MDM4/PPP2CA",5
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","2/99","36/2914",0.347489686459322,0.469715097647468,0.284245142298014,"GRB2/SRC",2
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/99","63/2914",0.362198957320747,0.483158462357375,0.292380310049848,"SMAD3/HDAC1/SP1",3
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","1/99","13/2914",0.362551584461812,0.483158462357375,0.292380310049848,"SRC",1
"R-HSA-3772470","R-HSA-3772470","Negative regulation of TCF-dependent signaling by WNT ligand antagonists","1/99","13/2914",0.362551584461812,0.483158462357375,0.292380310049848,"LRP6",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/99","13/2914",0.362551584461812,0.483158462357375,0.292380310049848,"CTNNB1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/99","13/2914",0.362551584461812,0.483158462357375,0.292380310049848,"EP300",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/99","13/2914",0.362551584461812,0.483158462357375,0.292380310049848,"SP1",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/99","13/2914",0.362551584461812,0.483158462357375,0.292380310049848,"EGFR",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","3/99","64/2914",0.371606529595655,0.494229207369674,0.299079701887851,"PRKACA/CXCR4/SRC",3
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"GRB2",1
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"JAK2",1
"R-HSA-4641257","R-HSA-4641257","Degradation of AXIN","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"AXIN1",1
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"EGFR",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"JAK2",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"PPP2CA",1
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"SMAD3",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"SRC",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/99","14/2914",0.384305253244397,0.501037026419224,0.303199410843706,"PPP2CA",1
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"JAK2",1
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"SMAD3",1
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"GRB2",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"AR",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"PRKACA",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"HDAC1",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"AKT1",1
"R-HSA-9617324","R-HSA-9617324","Negative regulation of NMDA receptor-mediated neuronal transmission","1/99","15/2914",0.405323798047434,0.520231127202628,0.314814600425191,"CAMK4",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","3/99","68/2914",0.408954374766051,0.523873724264263,0.317018895167481,"AP2M1/VAV2/SRC",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","4/99","97/2914",0.420764766035369,0.528839530760017,0.320023921791236,"MAPK3/PRKCD/JAK2/EGR1",4
"R-HSA-109704","R-HSA-109704","PI3K Cascade","2/99","42/2914",0.420935552915474,0.528839530760017,0.320023921791236,"GRB2/AKT2",2
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/99","42/2914",0.420935552915474,0.528839530760017,0.320023921791236,"CTNNB1/TCF7L2",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/99","42/2914",0.420935552915474,0.528839530760017,0.320023921791236,"MAPK14/PPP2CA",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/99","42/2914",0.420935552915474,0.528839530760017,0.320023921791236,"PRKACA/SMO",2
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"RPS6KB1",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"CDC25A",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"HDAC1",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"SRC",1
"R-HSA-4641263","R-HSA-4641263","Regulation of FZD by ubiquitination","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"LRP6",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"SRC",1
"R-HSA-5676590","R-HSA-5676590","NIK-->noncanonical NF-kB signaling","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"CHUK",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"RELA",1
"R-HSA-6788467","R-HSA-6788467","IL-6-type cytokine receptor ligand interactions","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"JAK2",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"TP53",1
"R-HSA-8950505","R-HSA-8950505","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","1/99","16/2914",0.425631815982343,0.528839530760017,0.320023921791236,"RALA",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","2/99","44/2914",0.444511929574262,0.545501958778404,0.330107085493739,"PRKACA/PPP2CA",2
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/99","17/2914",0.445253089349406,0.545501958778404,0.330107085493739,"PRKACA",1
"R-HSA-164952","R-HSA-164952","The role of Nef in HIV-1 replication and disease pathogenesis","1/99","17/2914",0.445253089349406,0.545501958778404,0.330107085493739,"AP2M1",1
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","1/99","17/2914",0.445253089349406,0.545501958778404,0.330107085493739,"GRB2",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/99","17/2914",0.445253089349406,0.545501958778404,0.330107085493739,"MDM2",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/99","17/2914",0.445253089349406,0.545501958778404,0.330107085493739,"HDAC1",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/99","17/2914",0.445253089349406,0.545501958778404,0.330107085493739,"YY1",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","3/99","72/2914",0.445644565416548,0.545501958778404,0.330107085493739,"EGFR/GRB2/SRC",3
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","3/99","73/2914",0.454685560606738,0.555540028763501,0.336181560522542,"ARRB2/GRK6/SRC",3
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/99","45/2914",0.456103415054691,0.55624420175489,0.336607686387226,"STAT3/GRB2",2
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","1/99","18/2914",0.464210612357487,0.559932873664779,0.338839863034662,"CASP3",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/99","18/2914",0.464210612357487,0.559932873664779,0.338839863034662,"PRKACA",1
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","1/99","18/2914",0.464210612357487,0.559932873664779,0.338839863034662,"GRB2",1
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","1/99","18/2914",0.464210612357487,0.559932873664779,0.338839863034662,"GRB2",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/99","18/2914",0.464210612357487,0.559932873664779,0.338839863034662,"EP300",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/99","18/2914",0.464210612357487,0.559932873664779,0.338839863034662,"E2F1",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","2/99","46/2914",0.467557531937582,0.562942675065103,0.340661225455433,"GRB2/AKT2",2
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/99","47/2914",0.478870180803184,0.572621353359882,0.346518216859233,"PPP2CA/SRC",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","2/99","47/2914",0.478870180803184,0.572621353359882,0.346518216859233,"PRKCD/JAK2",2
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/99","19/2914",0.482526616976481,0.572621353359882,0.346518216859233,"PRKCB",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/99","19/2914",0.482526616976481,0.572621353359882,0.346518216859233,"CTNNB1",1
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","1/99","19/2914",0.482526616976481,0.572621353359882,0.346518216859233,"GRB2",1
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","1/99","19/2914",0.482526616976481,0.572621353359882,0.346518216859233,"GRB2",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/99","19/2914",0.482526616976481,0.572621353359882,0.346518216859233,"HDAC1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/99","19/2914",0.482526616976481,0.572621353359882,0.346518216859233,"EP300",1
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","2/99","48/2914",0.490037692334802,0.580492678554308,0.351281499881578,"VAV2/MAPK8",2
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","6/99","165/2914",0.493754651564199,0.583849418039241,0.353312809706046,"EGFR/MAPK1/MAPK3/CREB1/GRB2/PRKCD",6
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/99","20/2914",0.500222597950343,0.585216172115356,0.354139892354225,"MAP2K4",1
"R-HSA-5357905","R-HSA-5357905","Regulation of TNFR1 signaling","1/99","20/2914",0.500222597950343,0.585216172115356,0.354139892354225,"CHUK",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/99","20/2914",0.500222597950343,0.585216172115356,0.354139892354225,"PRKACA",1
"R-HSA-5654706","R-HSA-5654706","FRS-mediated FGFR3 signaling","1/99","20/2914",0.500222597950343,0.585216172115356,0.354139892354225,"GRB2",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/99","20/2914",0.500222597950343,0.585216172115356,0.354139892354225,"EGFR",1
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","1/99","20/2914",0.500222597950343,0.585216172115356,0.354139892354225,"GRB2",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","2/99","50/2914",0.511924633968642,0.597848379952778,0.361784193617415,"GRB2/AKT2",2
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/99","21/2914",0.517319336997653,0.599908915360436,0.363031113682563,"SRC",1
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","1/99","21/2914",0.517319336997653,0.599908915360436,0.363031113682563,"GRB2",1
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","1/99","21/2914",0.517319336997653,0.599908915360436,0.363031113682563,"GRB2",1
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","1/99","21/2914",0.517319336997653,0.599908915360436,0.363031113682563,"GRB2",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","2/99","51/2914",0.522638665759119,0.603958318298563,0.365481584446936,"GRB2/AKT2",2
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","2/99","51/2914",0.522638665759119,0.603958318298563,0.365481584446936,"GRB2/AKT2",2
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/99","22/2914",0.53383692622587,0.610495169957267,0.369437319187453,"STAT3",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/99","22/2914",0.53383692622587,0.610495169957267,0.369437319187453,"SMAD3",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/99","22/2914",0.53383692622587,0.610495169957267,0.369437319187453,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/99","22/2914",0.53383692622587,0.610495169957267,0.369437319187453,"PRKACA",1
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","1/99","22/2914",0.53383692622587,0.610495169957267,0.369437319187453,"GRB2",1
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","1/99","22/2914",0.53383692622587,0.610495169957267,0.369437319187453,"GRB2",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/99","23/2914",0.549794790784528,0.622284857377694,0.376571774509951,"HDAC1",1
"R-HSA-5357769","R-HSA-5357769","Caspase activation via extrinsic apoptotic signalling pathway","1/99","23/2914",0.549794790784528,0.622284857377694,0.376571774509951,"CASP3",1
"R-HSA-5654693","R-HSA-5654693","FRS-mediated FGFR1 signaling","1/99","23/2914",0.549794790784528,0.622284857377694,0.376571774509951,"GRB2",1
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","1/99","23/2914",0.549794790784528,0.622284857377694,0.376571774509951,"GRB2",1
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","1/99","23/2914",0.549794790784528,0.622284857377694,0.376571774509951,"GRB2",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/99","23/2914",0.549794790784528,0.622284857377694,0.376571774509951,"E2F1",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/99","55/2914",0.563917951055703,0.637162713447322,0.385575015701859,"EP300/YY1",2
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/99","24/2914",0.565211710781875,0.637162713447322,0.385575015701859,"AR",1
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/99","86/2914",0.565831335542478,0.637162713447322,0.385575015701859,"SMAD3/HDAC1/SP1",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/99","56/2914",0.573836462559419,0.645078064203701,0.390364940516612,"PRKACA/PPP2CA",2
"R-HSA-2132295","R-HSA-2132295","MHC class II antigen presentation","1/99","25/2914",0.580105842488656,0.64662725444351,0.391302423263849,"AP2M1",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/99","25/2914",0.580105842488656,0.64662725444351,0.391302423263849,"PRKACA",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/99","25/2914",0.580105842488656,0.64662725444351,0.391302423263849,"PRKACA",1
"R-HSA-5654700","R-HSA-5654700","FRS-mediated FGFR2 signaling","1/99","25/2914",0.580105842488656,0.64662725444351,0.391302423263849,"GRB2",1
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","1/99","25/2914",0.580105842488656,0.64662725444351,0.391302423263849,"GRB2",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/99","26/2914",0.594494738851973,0.659330574465024,0.398989757618774,"PRKACA",1
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","1/99","26/2914",0.594494738851973,0.659330574465024,0.398989757618774,"GRB2",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/99","26/2914",0.594494738851973,0.659330574465024,0.398989757618774,"PRKACA",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/99","27/2914",0.608395369341465,0.669133675764906,0.404922042822939,"ARRB2",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/99","27/2914",0.608395369341465,0.669133675764906,0.404922042822939,"PRKACA",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/99","27/2914",0.608395369341465,0.669133675764906,0.404922042822939,"PRKACA",1
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","1/99","27/2914",0.608395369341465,0.669133675764906,0.404922042822939,"YY1",1
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","1/99","27/2914",0.608395369341465,0.669133675764906,0.404922042822939,"SRC",1
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"VAV2",1
"R-HSA-1236974","R-HSA-1236974","ER-Phagosome pathway","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"CHUK",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"SMAD3",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"PRKACA",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"AR",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"PRKACA",1
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"GRB2",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/99","28/2914",0.621824139149292,0.674919139536423,0.408423079901013,"EP300",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","2/99","62/2914",0.629926056306425,0.682592005276306,0.413066266430442,"TP53/CDC25A",2
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","1/99","29/2914",0.634796907764753,0.684503680314032,0.414223104577326,"PPP2CA",1
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","1/99","29/2914",0.634796907764753,0.684503680314032,0.414223104577326,"PPP2CA",1
"R-HSA-977225","R-HSA-977225","Amyloid fiber formation","1/99","29/2914",0.634796907764753,0.684503680314032,0.414223104577326,"SNCA",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/99","30/2914",0.647329006943709,0.695747111528117,0.421026996386152,"PLD2",1
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","1/99","30/2914",0.647329006943709,0.695747111528117,0.421026996386152,"GRB2",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/99","31/2914",0.659435258092313,0.706461435330663,0.427510702166815,"AKT1",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/99","31/2914",0.659435258092313,0.706461435330663,0.427510702166815,"RELA",1
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","1/99","32/2914",0.67112998908394,0.716667080427277,0.433686584222255,"GRB2",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/99","32/2914",0.67112998908394,0.716667080427277,0.433686584222255,"EP300",1
"R-HSA-1236975","R-HSA-1236975","Antigen processing-Cross presentation","1/99","33/2914",0.682427050527622,0.726383704345826,0.439566538182043,"CHUK",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/99","33/2914",0.682427050527622,0.726383704345826,0.439566538182043,"EP300",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","2/99","69/2914",0.688002710828064,0.731141144465193,0.442445473201327,"GRB2/SRC",2
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/99","34/2914",0.693339831505673,0.733276205800399,0.44373749216363,"MAPK3",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/99","34/2914",0.693339831505673,0.733276205800399,0.44373749216363,"PPP2CA",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/99","34/2914",0.693339831505673,0.733276205800399,0.44373749216363,"SRC",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/99","35/2914",0.703881274797665,0.740868666626205,0.448332022164118,"MAPK3",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/99","35/2914",0.703881274797665,0.740868666626205,0.448332022164118,"CTNNB1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/99","35/2914",0.703881274797665,0.740868666626205,0.448332022164118,"PRKACA",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/99","37/2914",0.72389977580847,0.760727745324958,0.460349618956102,"PRKACA",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/99","38/2914",0.733400617725384,0.769488584629331,0.465651185857386,"GSK3B",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/99","39/2914",0.742577717462931,0.777882521779711,0.470730724223728,"EP300",1
"R-HSA-380108","R-HSA-380108","Chemokine receptors bind chemokines","1/99","40/2914",0.75144199780073,0.785922722383358,0.475596201139702,"CXCR4",1
"R-HSA-162906","R-HSA-162906","HIV Infection","2/99","80/2914",0.76410963698409,0.797909115397289,0.482849691617119,"AP2M1/CXCR4",2
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/99","42/2914",0.768273979196123,0.798473428063895,0.483191181884354,"STAT3",1
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","1/99","42/2914",0.768273979196123,0.798473428063895,0.483191181884354,"PPP2CA",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/99","42/2914",0.768273979196123,0.798473428063895,0.483191181884354,"EGR1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/99","81/2914",0.770172355406413,0.799189838184676,0.48362471297106,"TP53/MAPK8",2
"R-HSA-382551","R-HSA-382551","Transport of small molecules","3/99","121/2914",0.788845465710888,0.816152495931473,0.493889558808758,"AP2M1/PRKACA/PHB",3
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/99","45/2914",0.79142853073852,0.816152495931473,0.493889558808758,"PRKACA",1
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","1/99","45/2914",0.79142853073852,0.816152495931473,0.493889558808758,"CHUK",1
"R-HSA-73894","R-HSA-73894","DNA Repair","4/99","157/2914",0.791458017991035,0.816152495931473,0.493889558808758,"TP53/EP300/MAPK8/YY1",4
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/99","46/2914",0.798625664045208,0.820982214516147,0.496812232687532,"YY1",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/99","46/2914",0.798625664045208,0.820982214516147,0.496812232687532,"TP53",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/99","125/2914",0.807117218045424,0.828423107341655,0.501315042264239,"MAPK1/MAPK14/PRKCD",3
"R-HSA-162909","R-HSA-162909","Host Interactions of HIV factors","1/99","49/2914",0.818774504447921,0.839085189829575,0.507767134541346,"AP2M1",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/99","51/2914",0.83108470832147,0.850382340867634,0.514603534564378,"E2F1",1
"R-HSA-162587","R-HSA-162587","HIV Life Cycle","1/99","53/2914",0.842566585910419,0.859469927911708,0.520102830808901,"CXCR4",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/99","53/2914",0.842566585910419,0.859469927911708,0.520102830808901,"PRKACA",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","1/99","56/2914",0.858356049694605,0.874227039827633,0.529033004434271,"PPP2CA",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/99","60/2914",0.876994879317485,0.89183633112132,0.539689156503068,"PPP2CA",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/99","61/2914",0.881261700252163,0.893426355623742,0.540651349847952,"PPP2CA",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/99","61/2914",0.881261700252163,0.893426355623742,0.540651349847952,"VAV2",1
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","1/99","62/2914",0.885381956710289,0.896228902581166,0.542347293543822,"PRKCB",1
"R-HSA-373080","R-HSA-373080","Class B/2 (Secretin family receptors)","1/99","65/2914",0.896912353930297,0.90651233325371,0.54857024705217,"SMO",1
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","1/99","70/2914",0.913631990728839,0.922001138735515,0.557943200445092,"CASP3",1
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","1/99","106/2914",0.976071647092648,0.983511217573537,0.595165638471127,"VAV2",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/99","115/2914",0.982685258064089,0.988668121126884,0.598286306279506,"CHUK",1
"R-HSA-375276","R-HSA-375276","Peptide ligand-binding receptors","1/99","153/2914",0.995633910413049,0.99925099713358,0.604690467251788,"CXCR4",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","1/99","157/2914",0.996227544797321,0.99925099713358,0.604690467251788,"CASP3",1
"R-HSA-373076","R-HSA-373076","Class A/1 (Rhodopsin-like receptors)","1/99","248/2914",0.999872119046702,0.999876961139575,0.605069265439985,"CXCR4",1
"R-HSA-500792","R-HSA-500792","GPCR ligand binding","2/99","317/2914",0.999876961139575,0.999876961139575,0.605069265439985,"SMO/CXCR4",2
